Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,268 | -154 | -364 | -4,780 | -4,125 |
| Depreciation Amortization | 136 | 81 | 39 | 3,322 | 3,317 |
| Accounts payable and accrued liabilities | 2 | 1 | 1 | 2 | 1 |
| Other Working Capital | 382 | 204 | 99 | 348 | 224 |
| Other Operating Activity | 150 | -426 | 59 | 367 | -54 |
| Operating Cash Flow | $-600 | $-293 | $-167 | $-740 | $-636 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 445 | 295 | 160 | 656 | N/A |
| Debt Issued | 478 | N/A | N/A | N/A | 615 |
| Financing Cash Flow | $923 | $295 | $160 | $656 | $615 |
| Beginning Cash Position | 106 | 106 | 106 | 190 | 190 |
| End Cash Position | 429 | 108 | 99 | 106 | 169 |
| Net Cash Flow | $323 | $2 | $-7 | $-84 | $-21 |
| Free Cash Flow | |||||
| Operating Cash Flow | -600 | -293 | -167 | -740 | -636 |
| Free Cash Flow | -600 | -293 | -167 | -740 | -636 |